Category - Developments

Developments

111 Inc. posts 96.1% jump in Q4 net revenue; beating guidance

Shanghai-based 111 Inc. (NASDAQ:YI) reported net revenue of $405.1-million (U.S.) in the fourth quarter of 2020, which was up 96.1%, from the year earlier quarter, beating its previous guidance of 81% to 90% growth. Net...

March 18, 2021

Developments

Hepion Pharma, ENDRA Life Sciences to collaborate in Hepion’s NASH trial

Hepion Pharmaceuticals (NASDAQ:HEPA) and ENDRA Life Sciences (NASDAQ:NDRA) signed a collaboration agreement to incorporate ENDRA’s Thermo Acoustic Enhanced UltraSound (TAEUS) as an add-on technology to support...

March 18, 2021

Developments

111, Inc. in strategic partnership with BeiGene

111, Inc. (NASDAQ:YI), a leading digital healthcare platform in China, entered into a strategic cooperation agreement with BeiGene (NASDAQ:BGNE; HKEX:06160), a commercial-stage and development biotechnology company...

March 17, 2021

Developments

111, Inc. achieves full distribution coverage across mainland China

111, Inc. (NASDAQ:YI) opened two new state-of-the-art, technology-driven fulfillment centers in the Northern cities of Xi’an and Shenyang, bringing the company’s total number of fulfillment centers to eight. The...

March 16, 2021

Developments

Coridea, Deerfield to accelerate medtech innovation at NYC site

Coridea and Deerfield Management have established Deerfield Device Design and Development Catalyst to advance medtech innovation and accelerate the formation of commercial companies. Coridea is a medtech incubator;...

March 9, 2021

Developments

Azura Ophthalmics posts positive Phase 2 results in Meibomian gland dysfunction

Closely held Azura Ophthalmics of Israel announced positive topline results from a Phase 2 program evaluating the company’s investigational therapy for the treatment of Meibomian gland dysfunction (MGD). The company’s...

March 5, 2021

Developments

BriaCell Therapeutics closes $25-million public offering

BriaCell Therapeutics (TSXV:BCT; NASDAQ:BCTX, BCTXW) closed a U.S. offering of 4,852,353 units at a price of $4.25 a unit and 1,030,000 pre-funded units at a price of $4.24 a unit for gross proceeds of about $25-million...

February 26, 2021

Developments

KA Imaging to present lateral dual-energy X-ray views at ECR 2021

Closely-held KA Imaging will present a poster on results from a study examining the feasibility of lateral chest dual-energy subtraction radiography using a stacked single-exposure multi-layer x-ray detector at the...

February 24, 2021

Developments

HEXO to acquire Zenabis Global

HEXO (TSX, NYSE:HEXO) agreed to acquire Zenabis Global (TSX:ZENA) by way of a court-approved plan of arrangement under the Business Corporations Act of British Columbia, in an all-share transaction valued at...

February 16, 2021

Developments

Notch Therapeutics in $85-million financing for stem cell cancer immunotherapies

Closely-held Notch Therapeutics closed an $85-million series A financing to support continuing development of its portfolio of induced pluripotent stem cell (iPSC)-derived T-cell therapeutic product candidates and...

February 10, 2021

Category - Developments

Subscribe